NEA Management Company as of Dec. 31, 2023
Portfolio Holdings for NEA Management Company
NEA Management Company holds 44 positions in its portfolio as reported in the December 2023 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Coursera (COUR) | 16.6 | $249M | 13M | 19.37 | |
Arcellx Common Stock (ACLX) | 13.9 | $208M | 3.7M | 55.50 | |
Rhythm Pharmaceuticals (RYTM) | 8.9 | $134M | 2.9M | 45.97 | |
Savara (SVRA) | 7.7 | $115M | 25M | 4.70 | |
Verona Pharma Sponsered Ads (VRNA) | 7.4 | $111M | 5.1M | 21.73 | |
Crispr Therapeutics Namen Akt (CRSP) | 6.6 | $99M | 1.6M | 62.60 | |
CVRX (CVRX) | 5.0 | $75M | 2.4M | 31.44 | |
Geron Corporation (GERN) | 3.2 | $48M | 23M | 2.11 | |
Monte Rosa Therapeutics (GLUE) | 2.9 | $44M | 7.7M | 5.65 | |
Korro Bio (KRRO) | 2.7 | $41M | 1.1M | 38.34 | |
Nextnav Common Stock (NN) | 2.4 | $36M | 8.2M | 4.45 | |
Aurinia Pharmaceuticals (AUPH) | 2.4 | $36M | 4.0M | 8.99 | |
Nkarta (NKTX) | 1.6 | $24M | 3.6M | 6.60 | |
Bright Health Group Com New (NEUE) | 1.3 | $20M | 2.7M | 7.28 | |
Sagimet Biosciences Com Ser A (SGMT) | 1.3 | $19M | 3.9M | 4.88 | |
Celcuity (CELC) | 1.2 | $18M | 1.3M | 14.57 | |
Phathom Pharmaceuticals (PHAT) | 1.2 | $18M | 2.0M | 9.13 | |
Allakos (ALLK) | 1.1 | $17M | 6.1M | 2.73 | |
ZeroFox Holdings | 1.0 | $16M | 18M | 0.87 | |
Trevi Therapeutics (TRVI) | 1.0 | $15M | 11M | 1.34 | |
Gossamer Bio (GOSS) | 1.0 | $15M | 16M | 0.91 | |
Adaptimmune Therapeutics Sponds Adr (ADAP) | 0.9 | $14M | 17M | 0.79 | |
X4 Pharmaceuticals (XFOR) | 0.8 | $13M | 15M | 0.84 | |
Black Diamond Therapeutics (BDTX) | 0.8 | $13M | 4.4M | 2.81 | |
Tuya Sponsered Ads (TUYA) | 0.8 | $11M | 4.9M | 2.30 | |
Synlogic Com New (SYBX) | 0.7 | $11M | 2.9M | 3.85 | |
Glycomimetics (GLYC) | 0.7 | $11M | 4.8M | 2.36 | |
Desktop Metal Com Cl A | 0.7 | $11M | 14M | 0.75 | |
Inozyme Pharma (INZY) | 0.7 | $10M | 2.4M | 4.26 | |
Champions Oncology Com New (CSBR) | 0.6 | $9.6M | 1.7M | 5.62 | |
Reneo Pharmaceuticals (RPHM) | 0.5 | $7.7M | 4.8M | 1.60 | |
Inventiva Sa Ads (IVA) | 0.4 | $6.6M | 1.5M | 4.52 | |
Marker Therapeutics Com New (MRKR) | 0.4 | $5.9M | 1.1M | 5.50 | |
Buzzfeed Class A Com | 0.3 | $3.8M | 15M | 0.25 | |
Lexicon Pharmaceuticals Com New (LXRX) | 0.2 | $3.6M | 2.4M | 1.53 | |
Senti Biosciences Ord (SNTI) | 0.2 | $2.9M | 4.4M | 0.66 | |
Affimed Therapeutics B V | 0.2 | $2.8M | 4.4M | 0.62 | |
Regulus Therapeutics | 0.2 | $2.5M | 1.9M | 1.28 | |
Mynd Ai Spon Ads (MYND) | 0.1 | $1.8M | 24M | 0.08 | |
Acrivon Therapeutics Common Stock (ACRV) | 0.1 | $1.3M | 430k | 2.99 | |
Ikena Oncology (IKNA) | 0.1 | $1.1M | 570k | 1.97 | |
Wheels Up Experience Com Cl A (UP) | 0.0 | $364k | 106k | 3.43 | |
Surf Air Mobility (SRFM) | 0.0 | $307k | 220k | 1.40 | |
Addex Therapeutics Sponsored Ads (ADXN) | 0.0 | $306k | 9.0k | 33.97 |